Phathom Pharma Upgraded by Barclays to Overweight $18 Target
Barclays lifts Phathom Pharmaceuticals to Overweight with an $18 target, citing a stronger 2026 revenue trajectory an...
Hardware wallets generally offer stronger offline protection, while software wallets trade convenience for higher risk. This overview helps decide.
21,982 articlesBarclays lifts Phathom Pharmaceuticals to Overweight with an $18 target, citing a stronger 2026 revenue trajectory an...
When a mining stock pops, traders look beyond a single catalyst. This article breaks down why coeur mining stock popp...
The latest consumer sentiment 56.4 reading sets the tone for retail stocks and the VanEck Retail ETF (RTH) in 2026. I...
Powell will continue to serve on the Federal Reserve Board after his chair term ends next month, steering a measured ...
Ethereum climbs on a market rebound after a golden cross formation sparks bullish chatter. Analysts say the setup cou...
As the nation nears its Semiquincentennial, a bold campaign seeks to make July 4, 2026 the largest day of charitable ...
Some markets now piled with homes for sale may surprise everyone by turning brighter in the next cycle. This guide ex...
Kennametal’s Q3 2026 results shed light on the company’s path through a challenging manufacturing environment. This a...
Gas prices keep rising, but major oil companies have not signaled a surge in drilling to curb the pump. Here’s what d...
A practical, plain‑language breakdown of Navigator NVGS's Q1 2026 earnings trajectory. Learn what drives revenue, how...
Stripe's Patrick Collison warns a surge in token theft is upending the AI startup landscape, forcing changes to free ...
States expand aid to middle-income buyers as mortgage costs and home prices stay elevated. The shift broadens access ...